— Know what they know.
Not Investment Advice

ANIP NASDAQ

ANI Pharmaceuticals, Inc.
1W: +4.0% 1M: +3.3% 3M: +6.4% YTD: +5.5% 1Y: +36.5% 3Y: +86.9% 5Y: +136.1%
$82.72
-0.05 (-0.06%)
 
Weekly Expected Move ±4.2%
$71 $75 $78 $81 $85
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Neutral · Power 62 · $1.9B mcap · 19M float · 1.89% daily turnover · Short 59% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
58.9 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: 16.9%  ·  5Y Avg: -2.2%
Cost Advantage
59
Intangibles
51
Switching Cost
66
Network Effect
72
Scale
47
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ANIP has a Narrow competitive edge (58.9/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Network Effects. ROIC of 16.9% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$109
Avg Target
$109
High
Based on 5 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 7Hold: 3Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$108.60
Analysts5
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-01-16 Guggenheim Vamil Divan $114 $124 +10 +45.4% $85.29
2025-10-09 Truist Financial $60 $90 +30 -1.8% $91.63
2025-09-17 H.C. Wainwright Brandon Folkes $94 $121 +27 +26.9% $95.36
2025-09-08 Guggenheim Vamil Divan $86 $114 +28 +19.7% $95.20
2025-08-08 Piper Sandler David Amsellem Initiated $94 +15.9% $81.13
2025-03-05 Guggenheim Initiated $86 +44.1% $59.68
2024-09-18 Raymond James Gary Nachman $48 $83 +35 +35.6% $61.23
2024-09-11 Truist Financial Les Sulewski Initiated $60 +8.1% $55.48
2024-06-26 H.C. Wainwright Oren Livnat $87 $94 +7 +43.5% $65.49
2024-05-13 H.C. Wainwright Oren Livnat Initiated $87 +27.8% $68.06
2022-08-09 Raymond James Initiated $48 +37.7% $34.87

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
May 22, 2026
DCF
1
ROE
4
ROA
5
D/E
2
P/E
2
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ANIP receives an overall rating of B. Strongest factors: ROE (4/5), ROA (5/5). Areas of concern: DCF (1/5), D/E (2/5), P/E (2/5), P/B (2/5).
Rating Change History
DateFromTo
2026-05-06 B- B
2026-04-30 B B-
2026-04-01 B- B
2026-02-27 C+ B-
2026-02-23 C C+
2026-01-12 D+ C

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

72 Grade A
Profitability
57
Balance Sheet
76
Earnings Quality
58
Growth
77
Value
64
Momentum
100
Safety
50
Cash Flow
76
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ANIP scores highest in Momentum (100/100) and lowest in Safety (50/100). An overall grade of A places ANIP among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.46
Grey Zone
Piotroski F-Score
6/9
Beneish M-Score
-2.53
Unlikely Manipulator
Ohlson O-Score
-7.67
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BBB+
Score: 64.5/100
Trend: Improving
Earnings Quality
75/100
OCF/NI: 2.33x
Accruals: -8.7%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ANIP scores 2.46, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ANIP scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ANIP's score of -2.53 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ANIP's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ANIP receives an estimated rating of BBB+ (score: 64.5/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). ANIP's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
19.29x
PEG
0.01x
P/S
2.04x
P/B
3.08x
P/FCF
10.00x
P/OCF
7.94x
EV/EBITDA
7.16x
EV/Revenue
1.84x
EV/EBIT
11.50x
EV/FCF
10.24x
Earnings Yield
5.41%
FCF Yield
10.00%
Shareholder Yield
1.27%
Graham Number
$48.48
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 19.3x earnings, ANIP trades at a reasonable valuation. An earnings yield of 5.4% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $48.48 per share, 71% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.773
NI / EBT
×
Interest Burden
0.787
EBT / EBIT
×
EBIT Margin
0.160
EBIT / Rev
×
Asset Turnover
0.678
Rev / Assets
×
Equity Multiplier
2.810
Assets / Equity
=
ROE
18.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ANIP's ROE of 18.5% is driven by Asset Turnover (0.678), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$35.38
Price/Value
2.17x
Margin of Safety
-117.38%
Premium
117.38%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with ANIP's realized 0.0% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. ANIP trades at a 117% premium to its adjusted intrinsic value of $35.38, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 19.3x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$82.72
Median 1Y
$75.34
5th Pctile
$32.63
95th Pctile
$173.88
Ann. Volatility
50.0%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Nikhil Lalwani
President and Chief Executive Officer
$837,409 $7,848,711 $10,278,620
Christopher K. Mutz
Senior Vice President, Head of Rare Disease
$471,625 $2,130,319 $3,396,694
Stephen P. Carey
Senior Vice President, Finance and Chief Financial Officer
$521,031 $2,130,319 $3,251,862
Meredith W. Cook
Senior Vice President, General Counsel and Corporate Secretary
$462,052 $1,457,614 $2,318,421
Ori Gutwerg President,
e President, Generics
$479,870 $1,345,411 $2,309,559

CEO Pay Ratio

31:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $10,278,620
Avg Employee Cost (SGA/emp): $327,572
Employees: 970

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
970
+8.1% YoY
Revenue / Employee
$910,687
Rev: $883,366,000
Profit / Employee
$80,760
NI: $78,337,000
SGA / Employee
$327,572
Avg labor cost proxy
R&D / Employee
$53,262
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -8.4% -10.8% -15.4% -22.7% -23.0% -24.5% -13.7% -7.6% -1.5% 3.8% 4.7% 8.9% 6.8% -1.8% -4.2% -4.8% -2.3% 8.6% 15.7% 18.5% 18.50%
ROA -3.8% -4.8% -6.9% -10.2% -10.3% -11.0% -6.3% -3.4% -0.7% 1.7% 2.3% 4.3% 3.2% -0.9% -1.7% -1.9% -0.9% 3.5% 5.6% 6.6% 6.58%
ROIC -2.0% -3.3% -5.8% -9.0% -8.6% -8.8% -4.8% -0.8% 2.6% 7.4% 8.5% 9.1% 7.3% 1.8% 0.1% 0.6% 1.3% 5.2% 15.7% 16.9% 16.92%
ROCE -2.7% -4.6% -6.5% -9.6% -9.1% -9.2% -5.2% -0.8% 2.9% 6.3% 6.2% 8.8% 7.5% 1.3% -0.4% -0.8% 0.4% 6.6% 11.6% 12.7% 12.69%
Gross Margin 54.1% 53.1% 44.4% 46.8% 52.2% 60.8% 61.5% 64.7% 63.7% 63.5% 59.4% 64.2% 58.2% 57.5% 57.9% 62.9% 64.7% 49.1% 96.2% 51.8% 51.78%
Operating Margin -32.0% -6.8% -38.9% -29.8% -17.5% -6.0% 1.9% 9.3% 10.6% 13.6% 5.1% 14.8% 3.7% -13.8% -2.3% 13.3% 6.6% 10.0% 19.5% 16.3% 16.30%
Net Margin -29.0% -8.5% -39.6% -31.2% -20.2% -10.3% -4.5% 1.3% 5.4% 7.5% 0.9% 13.2% -1.7% -16.3% -5.4% 8.0% 4.0% 10.6% 11.1% 12.4% 12.42%
EBITDA Margin -8.8% 12.9% -20.9% -7.3% 2.7% 12.4% 18.4% 23.0% 23.2% 25.1% 16.6% 32.5% 12.4% -9.0% 7.8% 24.5% 18.6% 26.8% 31.1% 25.1% 25.11%
FCF Margin -8.0% -7.3% -9.4% -27.1% -20.9% -18.6% -15.1% -2.1% 4.8% 11.8% 20.6% 18.4% 17.5% 13.4% 7.8% 7.3% 14.1% 16.4% 14.5% 17.9% 17.93%
OCF Margin 6.4% 4.6% 1.5% -16.1% -19.1% -13.8% -9.9% 2.6% 10.3% 15.5% 24.4% 22.4% 20.9% 16.7% 10.4% 12.0% 18.6% 20.6% 21.0% 22.6% 22.58%
ROE 3Y Avg snapshot only 6.48%
ROE 5Y Avg snapshot only -1.17%
ROA 3Y Avg snapshot only 2.84%
ROIC 3Y Avg snapshot only 7.54%
ROIC Economic snapshot only 11.58%
Cash ROA snapshot only 14.48%
Cash ROIC snapshot only 35.95%
CROIC snapshot only 28.54%
NOPAT Margin snapshot only 10.63%
Pretax Margin snapshot only 12.56%
R&D / Revenue snapshot only 5.60%
SGA / Revenue snapshot only 34.09%
SBC / Revenue snapshot only 3.15%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -24.60 -17.98 -15.34 -7.22 -7.59 -7.73 -13.71 -24.94 -186.30 82.98 56.43 37.77 45.54 -163.26 -58.03 -63.76 -129.76 50.73 22.09 18.48 19.294
P/S Ratio 1.99 1.87 3.02 2.01 1.92 1.85 2.08 1.83 2.39 2.47 2.18 2.59 2.28 2.08 1.75 1.99 1.77 2.34 1.90 1.79 2.036
P/B Ratio 2.16 2.03 1.82 1.26 1.35 1.46 1.94 1.94 2.84 3.28 2.32 2.93 2.69 2.53 2.51 3.13 3.09 4.51 3.10 3.06 3.077
P/FCF -24.87 -25.49 -32.18 -7.39 -9.20 -9.95 -13.78 -87.94 50.22 20.97 10.55 14.12 13.06 15.59 22.54 27.30 12.61 14.28 13.05 10.00 10.004
P/OCF 31.18 40.55 196.78 71.66 23.29 15.90 8.91 11.59 10.93 12.46 16.79 16.62 9.52 11.32 9.05 7.94 7.942
EV/EBITDA 17.62 21.37 269.82 -42.60 -76.84 -141.11 35.74 16.47 15.12 13.21 10.55 11.11 11.10 17.42 24.52 27.15 20.19 14.70 7.60 7.16 7.159
EV/Revenue 2.82 2.71 3.89 2.83 2.67 2.51 2.83 2.49 2.99 3.00 2.31 2.72 2.40 2.20 2.52 2.69 2.41 2.91 1.94 1.84 1.836
EV/EBIT -58.13 -32.77 -19.05 -9.71 -10.72 -11.32 -25.86 -163.66 63.03 32.19 24.02 21.04 22.76 124.33 -335.76 -200.02 397.79 33.30 12.77 11.50 11.499
EV/FCF -35.32 -36.89 -41.38 -10.44 -12.77 -13.50 -18.78 -119.85 62.67 25.47 11.19 14.80 13.74 16.45 32.45 36.93 17.11 17.77 13.35 10.24 10.243
Earnings Yield -4.1% -5.6% -6.5% -13.8% -13.2% -12.9% -7.3% -4.0% -0.5% 1.2% 1.8% 2.6% 2.2% -0.6% -1.7% -1.6% -0.8% 2.0% 4.5% 5.4% 5.41%
FCF Yield -4.0% -3.9% -3.1% -13.5% -10.9% -10.1% -7.3% -1.1% 2.0% 4.8% 9.5% 7.1% 7.7% 6.4% 4.4% 3.7% 7.9% 7.0% 7.7% 10.0% 10.00%
PEG Ratio snapshot only 0.014
EV/OCF snapshot only 8.132
EV/Gross Profit snapshot only 2.785
Acquirers Multiple snapshot only 13.724
Shareholder Yield snapshot only 1.27%
Graham Number snapshot only $48.48
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 2.17 2.17 3.68 3.68 3.68 3.68 3.46 3.46 3.46 3.46 3.57 3.57 3.57 3.57 2.72 2.72 2.72 2.72 2.71 2.71 2.708
Quick Ratio 1.39 1.39 2.74 2.74 2.74 2.74 2.40 2.40 2.40 2.40 2.81 2.81 2.81 2.81 2.02 2.02 2.02 2.02 2.19 2.19 2.194
Debt/Equity 0.95 0.95 0.80 0.80 0.80 0.80 0.85 0.85 0.85 0.85 0.62 0.62 0.62 0.62 1.46 1.46 1.46 1.46 0.60 0.60 0.601
Net Debt/Equity 0.91 0.91 0.52 0.52 0.52 0.52 0.70 0.70 0.70 0.70 0.14 0.14 0.14 0.14 1.10 1.10 1.10 1.10 0.07 0.07 0.073
Debt/Assets 0.40 0.40 0.37 0.37 0.37 0.37 0.38 0.38 0.38 0.38 0.32 0.32 0.32 0.32 0.49 0.49 0.49 0.49 0.23 0.23 0.226
Debt/EBITDA 5.44 6.90 92.22 -19.11 -32.96 -57.03 11.44 5.27 3.61 2.81 2.68 2.26 2.45 4.07 9.89 9.33 7.01 3.81 1.44 1.37 1.372
Net Debt/EBITDA 5.21 6.61 60.04 -12.44 -21.46 -37.12 9.52 4.39 3.00 2.33 0.61 0.51 0.55 0.92 7.49 7.07 5.31 2.89 0.18 0.17 0.167
Interest Coverage -1.03 -1.75 -3.70 -4.10 -3.09 -2.51 -1.23 -0.19 0.64 1.46 1.74 2.81 2.66 0.57 -0.26 -0.43 0.18 2.67 3.06 4.61 4.607
Equity Multiplier 2.36 2.36 2.15 2.15 2.15 2.15 2.25 2.25 2.25 2.25 1.98 1.98 1.98 1.98 3.00 3.00 3.00 3.00 2.66 2.66 2.664
Cash Ratio snapshot only 1.027
Debt Service Coverage snapshot only 7.400
Cash to Debt snapshot only 0.878
FCF to Debt snapshot only 0.509
Defensive Interval snapshot only 426.1 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.46 0.46 0.35 0.37 0.41 0.46 0.41 0.47 0.52 0.59 0.58 0.62 0.65 0.67 0.56 0.62 0.68 0.76 0.65 0.68 0.678
Inventory Turnover 1.60 1.67 1.41 1.61 1.79 1.91 1.48 1.52 1.60 1.76 1.68 1.78 1.92 2.06 2.02 2.21 2.35 2.77 1.95 2.25 2.249
Receivables Turnover 2.54 2.53 1.93 2.02 2.24 2.52 2.15 2.44 2.73 3.06 2.97 3.16 3.29 3.39 3.20 3.51 3.89 4.31 3.51 3.67 3.674
Payables Turnover 6.72 7.06 5.88 6.71 7.47 7.97 5.31 5.44 5.71 6.29 5.50 5.85 6.32 6.77 6.08 6.66 7.07 8.35 5.05 5.81 5.814
DSO 144 144 189 181 163 145 170 150 134 119 123 116 111 108 114 104 94 85 104 99 99.3 days
DIO 229 218 258 226 203 191 246 240 229 208 218 205 190 177 181 165 156 132 187 162 162.3 days
DPO 54 52 62 54 49 46 69 67 64 58 66 62 58 54 60 55 52 44 72 63 62.8 days
Cash Conversion Cycle 318 310 386 353 317 290 347 323 299 269 274 258 243 231 235 214 198 173 219 199 198.9 days
Fixed Asset Turnover snapshot only 14.785
Operating Cycle snapshot only 261.7 days
Cash Velocity snapshot only 3.234
Capital Intensity snapshot only 1.559
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 8.0% 6.7% 3.7% 6.0% 17.8% 33.2% 46.4% 58.6% 59.7% 58.8% 53.9% 44.3% 34.3% 23.6% 26.2% 30.3% 38.7% 48.9% 43.8% 37.0% 37.03%
Net Income 15.4% 6.9% -88.9% -3.1% -2.7% -2.1% -12.4% 58.1% 91.9% 1.2% 1.4% 2.4% 6.2% -1.5% -2.0% -1.6% -1.4% 6.4% 5.1% 5.3% 5.26%
EPS 16.2% 7.7% -59.8% -2.0% -1.7% -1.3% 2.3% 59.1% 92.6% 1.2% 1.3% 2.1% 5.8% -1.5% -2.0% -1.6% -1.4% 5.9% 4.8% 5.0% 4.96%
FCF -14.7% 63.0% 61.7% -3.7% -2.1% -2.4% -1.3% 87.8% 1.4% 2.0% 3.1% 13.7% 3.9% 40.3% -52.5% -48.3% 11.5% 82.2% 1.7% 2.4% 2.37%
EBITDA 38.1% 23.2% -88.9% -1.4% -1.3% -1.2% 7.0% 4.6% 10.1% 21.3% 3.3% 1.3% 47.1% -31.3% -40.8% -47.2% -23.7% 1.3% 2.6% 2.5% 2.54%
Op. Income 43.2% 25.1% -1.5% -11.1% -5.3% -2.9% 11.3% 90.0% 1.3% 1.7% 2.3% 10.3% 1.6% -72.2% -98.8% -88.7% -69.7% 4.0% 189.2% 18.1% 18.12%
OCF Growth snapshot only 1.58%
Asset Growth snapshot only 12.21%
Equity Growth snapshot only 26.18%
Debt Growth snapshot only -47.89%
Shares Change snapshot only 7.47%
Dividend Growth snapshot only -53.78%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 4.1% 3.5% 2.4% 2.8% 5.3% 9.5% 15.3% 20.8% 26.7% 31.2% 32.7% 34.4% 36.2% 37.8% 41.7% 43.9% 43.8% 42.9% 40.8% 37.1% 37.07%
Revenue 5Y 18.9% 14.4% 10.9% 9.3% 9.7% 11.0% 12.3% 14.0% 16.2% 18.6% 19.3% 20.0% 20.2% 20.8% 24.4% 27.1% 30.5% 32.9% 33.5% 34.1% 34.07%
EPS 3Y
EPS 5Y 88.9% -5.6% 9.8% -0.1%
Net Income 3Y
Net Income 5Y 1.1% 4.1% 21.3% 9.3%
EBITDA 3Y -17.7% -24.8% -64.3% -25.6% 7.5% 47.5% 67.2% 55.9% 49.1% 50.6% 37.6% 1.7% 1.1% 63.4% 63.39%
EBITDA 5Y -3.9% -9.8% -41.0% -15.0% -1.9% 5.4% 10.0% 9.2% 11.3% 8.5% -1.5% 0.8% 8.9% 29.2% 49.6% 51.7% 44.0% 44.05%
Gross Profit 3Y 4.6% 0.8% -3.5% -7.6% -6.1% -0.8% 7.4% 17.6% 27.3% 33.9% 36.0% 36.4% 37.8% 39.9% 46.6% 53.2% 54.6% 48.8% 50.9% 41.2% 41.17%
Gross Profit 5Y 13.2% 10.7% 7.7% 6.0% 7.2% 9.7% 12.7% 15.9% 18.0% 19.2% 18.9% 18.2% 17.3% 17.2% 20.5% 24.6% 30.1% 32.4% 38.1% 36.6% 36.64%
Op. Income 3Y
Op. Income 5Y -8.9% 6.1% 5.8% 11.6% 7.3% -18.5% -48.6% 9.5%
FCF 3Y 61.2%
FCF 5Y 42.3% 12.3% 26.4% 27.5% 12.7% 21.9% 48.8% 48.79%
OCF 3Y -40.5% -44.0% -63.3% -34.8% -5.7% 39.4% 98.3% 50.1% 1.0% 1.1% 1.7% 1.8% 1.83%
OCF 5Y -14.2% -13.4% -34.5% -30.3% -8.5% 4.6% 12.1% 14.7% 15.6% 6.4% 7.0% 19.6% 23.1% 45.9% 64.7% 43.5% 43.55%
Assets 3Y 3.8% 3.8% 21.5% 21.5% 21.5% 21.5% 18.5% 18.5% 18.5% 18.5% 25.2% 25.2% 25.2% 25.2% 18.5% 18.5% 18.5% 18.5% 23.7% 23.7% 23.75%
Assets 5Y 10.1% 10.1% 19.0% 19.0% 19.0% 19.0% 13.0% 13.0% 13.0% 13.0% 16.0% 16.0% 16.0% 16.0% 23.0% 23.0% 23.0% 23.0% 25.6% 25.6% 25.58%
Equity 3Y 3.8% 3.8% 22.1% 22.1% 22.1% 22.1% 16.7% 16.7% 16.7% 16.7% 32.7% 32.7% 32.7% 32.7% 6.1% 6.1% 6.1% 6.1% 16.9% 16.9% 16.89%
Book Value 3Y 3.0% 3.0% 14.7% 10.0% 11.1% 10.5% 5.0% 4.6% 2.2% -0.1% 13.4% 13.1% 13.5% 13.4% -4.5% -1.3% -1.4% -2.6% 7.1% 7.0% 7.02%
Dividend 3Y 84.0% 25.3% 2.8% -10.2% -14.5% -14.8% -14.5% -14.6% -10.0% -7.0% -7.1% -9.4% -18.2% -29.2% -29.22%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.75 0.74 0.79 0.84 0.81 0.72 0.67 0.62 0.64 0.66 0.66 0.70 0.74 0.79 0.83 0.86 0.89 0.89 0.91 0.94 0.940
Earnings Stability 0.48 0.53 0.58 0.59 0.66 0.72 0.79 0.55 0.27 0.10 0.09 0.00 0.01 0.01 0.00 0.02 0.20 0.41 0.52 0.50 0.496
Margin Stability 0.89 0.92 0.90 0.88 0.87 0.88 0.89 0.89 0.91 0.92 0.93 0.89 0.88 0.89 0.90 0.90 0.90 0.93 0.92 0.96 0.956
Rev. Growth Consistency 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.50 0.50 0.50 0.50 0.95 0.50 0.50 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.200
Earnings Smoothness
ROE Trend -0.08 -0.10 -0.08 -0.13 -0.09 -0.08 -0.02 0.05 0.12 0.19 0.17 0.20 0.16 0.06 0.01 -0.05 -0.05 0.08 0.14 0.15 0.152
Gross Margin Trend -0.06 -0.08 -0.10 -0.14 -0.11 -0.07 0.00 0.06 0.09 0.09 0.08 0.08 0.05 0.02 -0.00 -0.02 -0.01 -0.03 0.08 0.05 0.049
FCF Margin Trend -0.11 -0.06 -0.01 -0.25 -0.13 -0.04 0.02 0.06 0.19 0.25 0.33 0.33 0.26 0.17 0.05 -0.01 0.03 0.04 0.00 0.05 0.051
Sustainable Growth Rate 3.4% 4.3% 8.5% 6.4% 8.2% 15.4% 18.3% 18.35%
Internal Growth Rate 1.6% 2.1% 4.2% 3.1% 3.5% 5.8% 7.0% 6.98%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income -0.79 -0.44 -0.08 0.58 0.75 0.58 0.65 -0.35 -8.00 5.22 6.33 3.26 4.17 -13.10 -3.46 -3.84 -13.62 4.48 2.44 2.33 2.327
FCF/OCF -1.25 -1.59 -6.12 1.69 1.09 1.35 1.53 -0.81 0.46 0.76 0.84 0.82 0.84 0.80 0.75 0.61 0.76 0.79 0.69 0.79 0.794
FCF/Net Income snapshot only 1.847
OCF/EBITDA snapshot only 0.880
CapEx/Revenue 14.3% 12.0% 10.9% 11.1% 1.8% 4.8% 5.2% 4.6% 5.5% 3.8% 3.8% 4.0% 3.4% 3.4% 2.7% 4.7% 4.6% 4.3% 6.4% 4.7% 4.66%
CapEx/Depreciation snapshot only 0.481
Accruals Ratio -0.07 -0.07 -0.07 -0.04 -0.03 -0.05 -0.02 -0.05 -0.06 -0.07 -0.12 -0.10 -0.10 -0.12 -0.08 -0.09 -0.14 -0.12 -0.08 -0.09 -0.087
Sloan Accruals snapshot only 0.038
Cash Flow Adequacy snapshot only 4.767
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.1% 0.2% 0.3% 0.2% 0.2% 0.2% 0.1% 0.2% 0.1% 0.1% 0.1% 0.2% 0.1% 0.1% 0.1% 0.1% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.01 $0.04 $0.06 $0.09 $0.10 $0.10 $0.09 $0.09 $0.08 $0.08 $0.08 $0.08 $0.08 $0.08 $0.08 $0.07 $0.05 $0.03 $0.00
Payout Ratio 12.2% 8.7% 4.6% 6.0% 4.1% 1.5% 0.8% 0.84%
FCF Payout Ratio 8.5% 3.1% 1.6% 1.7% 1.7% 2.2% 3.4% 3.3% 1.5% 1.2% 0.9% 0.5% 0.45%
Total Payout Ratio 43.6% 31.6% 31.1% 43.7% 31.2% 15.5% 23.6% 23.55%
Div. Increase Streak 0 0 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0
Chowder Number 7.56 1.74 0.62 0.16 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.04 -0.29 -0.54 -0.537
Buyback Yield 0.2% 0.2% 0.1% 0.4% 0.3% 0.4% 0.3% 0.7% 0.5% 0.4% 0.4% 0.7% 0.8% 0.9% 1.0% 0.9% 0.8% 0.5% 0.6% 1.2% 1.23%
Net Buyback Yield 0.2% 0.2% -14.6% -20.9% -19.6% -18.0% 0.3% 0.7% -8.1% -7.0% -7.3% -5.4% 0.7% 0.9% 0.8% 0.7% 0.7% 0.4% 0.6% 1.1% 1.09%
Total Shareholder Return 0.2% 0.2% -14.6% -20.7% -19.4% -17.8% 0.5% 0.9% -7.9% -6.8% -7.2% -5.3% 0.9% 1.0% 0.9% 0.8% 0.8% 0.5% 0.7% 1.1% 1.14%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.84 0.80 0.76 0.77 0.77 0.77 0.76 0.76 0.49 1.01 0.94 0.83 0.76 0.95 0.83 0.76 0.69 0.75 0.79 0.77 0.773
Interest Burden (EBT/EBIT) 1.97 1.57 1.27 1.24 1.32 1.40 1.81 6.33 -0.55 0.31 0.42 0.64 0.62 -0.76 4.82 3.04 -3.26 0.70 0.71 0.79 0.787
EBIT Margin -0.05 -0.08 -0.20 -0.29 -0.25 -0.22 -0.11 -0.02 0.05 0.09 0.10 0.13 0.11 0.02 -0.01 -0.01 0.01 0.09 0.15 0.16 0.160
Asset Turnover 0.46 0.46 0.35 0.37 0.41 0.46 0.41 0.47 0.52 0.59 0.58 0.62 0.65 0.67 0.56 0.62 0.68 0.76 0.65 0.68 0.678
Equity Multiplier 2.25 2.25 2.22 2.22 2.22 2.22 2.20 2.20 2.20 2.20 2.09 2.09 2.09 2.09 2.47 2.47 2.47 2.47 2.81 2.81 2.810
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-1.42 $-1.83 $-3.00 $-3.89 $-3.91 $-4.16 $-2.93 $-1.59 $-0.29 $0.70 $0.98 $1.83 $1.40 $-0.37 $-0.95 $-1.05 $-0.50 $1.81 $3.57 $4.16 $4.16
Book Value/Share $16.19 $16.16 $25.29 $22.23 $22.05 $22.00 $20.74 $20.48 $18.96 $17.70 $23.81 $23.56 $23.68 $23.58 $22.04 $21.38 $21.10 $20.32 $25.47 $25.10 $26.89
Tangible Book/Share $0.30 $0.30 $2.59 $2.28 $2.26 $2.25 $3.59 $3.55 $3.29 $3.07 $11.47 $11.35 $11.41 $11.36 $-8.91 $-8.64 $-8.53 $-8.22 $-0.06 $-0.06 $-0.06
Revenue/Share $17.66 $17.55 $15.24 $14.01 $15.45 $17.36 $19.38 $21.70 $22.48 $23.50 $25.33 $26.64 $27.89 $28.63 $31.60 $33.63 $36.80 $39.20 $41.61 $42.88 $44.17
FCF/Share $-1.41 $-1.29 $-1.43 $-3.80 $-3.22 $-3.23 $-2.92 $-0.45 $1.07 $2.77 $5.23 $4.89 $4.88 $3.83 $2.45 $2.45 $5.17 $6.42 $6.05 $7.69 $7.92
OCF/Share $1.12 $0.81 $0.23 $-2.25 $-2.95 $-2.39 $-1.91 $0.55 $2.31 $3.65 $6.19 $5.96 $5.83 $4.79 $3.29 $4.03 $6.85 $8.09 $8.73 $9.68 $9.97
Cash/Share $0.65 $0.65 $7.07 $6.22 $6.16 $6.15 $2.95 $2.92 $2.70 $2.52 $11.51 $11.39 $11.44 $11.40 $7.77 $7.54 $7.44 $7.17 $13.45 $13.26 $14.88
EBITDA/Share $2.82 $2.22 $0.22 $-0.93 $-0.54 $-0.31 $1.53 $3.29 $4.44 $5.34 $5.55 $6.52 $6.04 $3.62 $3.25 $3.34 $4.38 $7.76 $10.63 $11.00 $11.00
Debt/Share $15.36 $15.34 $20.26 $17.81 $17.66 $17.63 $17.55 $17.33 $16.05 $14.98 $14.86 $14.71 $14.79 $14.72 $32.10 $31.13 $30.73 $29.59 $15.32 $15.09 $15.09
Net Debt/Share $14.71 $14.69 $13.19 $11.59 $11.50 $11.47 $14.60 $14.41 $13.35 $12.46 $3.36 $3.32 $3.34 $3.33 $24.32 $23.59 $23.29 $22.42 $1.87 $1.84 $1.84
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 2.457
Altman Z-Prime snapshot only 4.733
Piotroski F-Score 5 5 4 3 3 4 3 5 5 6 7 7 7 5 4 4 5 6 7 6 6
Beneish M-Score -2.40 -2.39 -2.37 -2.12 -2.11 -2.23 -2.37 -2.45 -2.50 -2.51 -2.94 -2.90 -2.94 -3.11 -2.15 -2.24 -2.43 -2.15 -2.83 -2.53 -2.534
Ohlson O-Score snapshot only -7.673
Net-Net WC snapshot only $-6.80
EVA snapshot only $40134697.74
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BBB+
Credit Score 29.48 28.87 30.73 35.37 35.61 36.35 32.21 34.95 47.79 57.51 62.63 70.51 65.56 52.96 31.78 31.41 36.28 54.19 65.45 64.47 64.470
Credit Grade snapshot only 8
Credit Trend snapshot only 33.060
Implied Spread (bps) snapshot only 225.000
Industry Credit Rank snapshot only 54
Sector Credit Rank snapshot only 62

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms